APA (7th ed.) Citation

Carri, I., Carri, I., Schwab, E., Trivino, J. C., Euw, E. M. v., Nielsen, M., . . . Barrio, M. M. VACCIMEL, an allogeneic melanoma vaccine, efficiently triggers T cell immune responses against neoantigens and alloantigens, as well as against tumor-associated antigens. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Carri, Ibel, Ibel Carri, Erika Schwab, Juan Carlos Trivino, Erika M. von Euw, Morten Nielsen, Morten Nielsen, José Mordoh, and María Marcela Barrio. VACCIMEL, an Allogeneic Melanoma Vaccine, Efficiently Triggers T Cell Immune Responses Against Neoantigens and Alloantigens, as Well as Against Tumor-associated Antigens. Frontiers Media S.A.

MLA (9th ed.) Citation

Carri, Ibel, et al. VACCIMEL, an Allogeneic Melanoma Vaccine, Efficiently Triggers T Cell Immune Responses Against Neoantigens and Alloantigens, as Well as Against Tumor-associated Antigens. Frontiers Media S.A.